View Financial HealthMacmic Science&TechnologyLtd 배당 및 자사주 매입배당 기준 점검 0/6Macmic Science&TechnologyLtd 현재 배당금을 지급하지 않습니다.핵심 정보0%배당 수익률-0.05%자사주 매입 수익률총 주주 수익률-0.05%미래 배당 수익률0%배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향0%최근 배당 및 자사주 매입 업데이트공시 • Dec 06Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces an Equity Buyback for CNY 50 million worth of its shares.Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at no more than CNY 30.12 per share. The purpose of the program is to use the repurchased shares for equity incentives or employee stock ownership plans or for converting corporate bonds issued by listed companies that can be converted into shares. If the company fails to use the shares for said purposes within 3 years of completion of the program, the unused or not transferred shares will be cancelled. The program will be funded from company's own funds. The plan will be valid for 12 months.공시 • Mar 01Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces an Equity Buyback for CNY 50 million worth of its shares.Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at no more than CNY 46.99 per share. The purpose of the program is to use the repurchased shares for equity incentives or employee stock ownership plans or for converting corporate bonds issued by listed companies that can be converted into . If the company fails to use the shares for said purposes within 3 years of completion of the program, the unused or not transferred shares will be cancelled. The program will be funded from company's own funds. The plan will be valid for 6 months.모든 업데이트 보기Recent updatesBuy Or Sell Opportunity • May 21Now 27% undervaluedThe stock has been flat over the last 90 days, currently trading at CN¥32.57. The fair value is estimated to be CN¥44.50, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable.New Risk • May 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 36% per year over the past 5 years. Minor Risks High level of debt (55% net debt to equity). Share price has been volatile over the past 3 months (8.3% average weekly change). Large one-off items impacting financial results.Reported Earnings • May 01Full year 2025 earnings released: EPS: CN¥0.08 (vs CN¥0.068 loss in FY 2024)Full year 2025 results: EPS: CN¥0.08 (up from CN¥0.068 loss in FY 2024). Revenue: CN¥1.35b (up 1.2% from FY 2024). Net income: CN¥17.1m (up CN¥31.6m from FY 2024). Profit margin: 1.3% (up from net loss in FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.공시 • Apr 30Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 20, 2026Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 20, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Changzhou, Jiangsu China공시 • Mar 30Macmic Science&Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 30, 2026Macmic Science&Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026Reported Earnings • Mar 05Full year 2025 earnings released: EPS: CN¥0.082 (vs CN¥0.068 loss in FY 2024)Full year 2025 results: EPS: CN¥0.082 (up from CN¥0.068 loss in FY 2024). Revenue: CN¥1.35b (up 1.1% from FY 2024). Net income: CN¥17.4m (up CN¥31.9m from FY 2024). Profit margin: 1.3% (up from net loss in FY 2024). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance.공시 • Dec 26Macmic Science&Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 30, 2026Macmic Science&Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 30, 2026Reported Earnings • Oct 31Third quarter 2025 earnings released: EPS: CN¥0.011 (vs CN¥0.007 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.011 (up from CN¥0.007 in 3Q 2024). Revenue: CN¥302.9m (down 12% from 3Q 2024). Net income: CN¥2.39m (up 56% from 3Q 2024). Profit margin: 0.8% (up from 0.4% in 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.공시 • Sep 30Macmic Science&Technology Co.,Ltd. to Report Q3, 2025 Results on Oct 31, 2025Macmic Science&Technology Co.,Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025New Risk • Aug 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (13% operating cash flow to total debt). Earnings have declined by 11% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.0% average weekly change).공시 • Jun 30Macmic Science&Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 29, 2025Macmic Science&Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 29, 2025New Risk • Jun 05New major risk - Revenue and earnings growthEarnings have declined by 11% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (13% operating cash flow to total debt). Earnings have declined by 11% per year over the past 5 years.Reported Earnings • Apr 20Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: CN¥0.068 loss per share (down from CN¥0.55 profit in FY 2023). Revenue: CN¥1.33b (down 12% from FY 2023). Net loss: CN¥14.5m (down 113% from profit in FY 2023). Revenue missed analyst estimates by 4.0%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 21% p.a. on average during the next 2 years, compared to a 23% growth forecast for the Semiconductor industry in China. Over the last 3 years on average, earnings per share has fallen by 24% per year whereas the company’s share price has fallen by 21% per year.공시 • Apr 15Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 09, 2025Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 09, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Changzhou, Jiangsu ChinaNew Risk • Apr 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (7.3% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (7.7% average weekly change).공시 • Mar 28Macmic Science&Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 29, 2025Macmic Science&Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025Reported Earnings • Mar 02Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: CN¥0.066 loss per share (down from CN¥0.55 profit in FY 2023). Revenue: CN¥1.33b (down 12% from FY 2023). Net loss: CN¥14.1m (down 112% from profit in FY 2023). Revenue missed analyst estimates by 4.0%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 21% p.a. on average during the next 2 years, compared to a 24% growth forecast for the Semiconductor industry in China. Over the last 3 years on average, earnings per share has fallen by 24% per year whereas the company’s share price has fallen by 27% per year.공시 • Dec 27Macmic Science&Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025Macmic Science&Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025공시 • Dec 06Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces an Equity Buyback for CNY 50 million worth of its shares.Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at no more than CNY 30.12 per share. The purpose of the program is to use the repurchased shares for equity incentives or employee stock ownership plans or for converting corporate bonds issued by listed companies that can be converted into shares. If the company fails to use the shares for said purposes within 3 years of completion of the program, the unused or not transferred shares will be cancelled. The program will be funded from company's own funds. The plan will be valid for 12 months.분석 기사 • Nov 11Macmic Science&Technology Co.,Ltd.'s (SHSE:688711) Shares Leap 28% Yet They're Still Not Telling The Full StoryDespite an already strong run, Macmic Science&Technology Co.,Ltd. ( SHSE:688711 ) shares have been powering on, with a...Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.007 (vs CN¥0.11 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.007 (down from CN¥0.11 in 3Q 2023). Revenue: CN¥343.1m (down 7.5% from 3Q 2023). Net income: CN¥1.53m (down 93% from 3Q 2023). Profit margin: 0.4% (down from 6.2% in 3Q 2023). Revenue is forecast to grow 29% p.a. on average during the next 3 years, compared to a 23% growth forecast for the Semiconductor industry in China. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 36% per year, which means it is performing significantly worse than earnings.분석 기사 • Oct 16Macmic Science&TechnologyLtd (SHSE:688711) Will Want To Turn Around Its Return TrendsIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥17.40, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 32x in the Semiconductor industry in China. Total loss to shareholders of 73% over the past three years.공시 • Sep 30Macmic Science&Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 31, 2024Macmic Science&Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 24%After last week's 24% share price gain to CN¥14.80, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 27x in the Semiconductor industry in China. Total loss to shareholders of 70% over the past three years.분석 기사 • Sep 26Why We're Not Concerned About Macmic Science&Technology Co.,Ltd.'s (SHSE:688711) Share PriceWhen close to half the companies in China have price-to-earnings ratios (or "P/E's") below 27x, you may consider Macmic...New Risk • Sep 14New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.5x net interest cover). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.1% net profit margin).분석 기사 • Aug 29We Think That There Are More Issues For Macmic Science&TechnologyLtd (SHSE:688711) Than Just Sluggish EarningsA lackluster earnings announcement from Macmic Science&Technology Co.,Ltd. ( SHSE:688711 ) last week didn't sink the...Reported Earnings • Aug 23Second quarter 2024 earnings released: EPS: CN¥0.023 (vs CN¥0.15 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.023 (down from CN¥0.15 in 2Q 2023). Revenue: CN¥390.2m (down 9.9% from 2Q 2023). Net income: CN¥4.23m (down 87% from 2Q 2023). Profit margin: 1.1% (down from 7.3% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Semiconductor industry in China.New Risk • Jul 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (25% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Profit margins are more than 30% lower than last year (5.9% net profit margin).분석 기사 • Jul 22Is It Too Late To Consider Buying Macmic Science&Technology Co.,Ltd. (SHSE:688711)?Macmic Science&Technology Co.,Ltd. ( SHSE:688711 ), might not be a large cap stock, but it saw a double-digit share...공시 • Jun 28Macmic Science&Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 23, 2024Macmic Science&Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 23, 2024분석 기사 • Jun 13Is Macmic Science&TechnologyLtd (SHSE:688711) A Risky Investment?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Valuation Update With 7 Day Price Move • Jun 13Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥24.77, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 31x in the Semiconductor industry in China. Total loss to shareholders of 60% over the past year.Reported Earnings • Apr 27First quarter 2024 earnings released: CN¥0.01 loss per share (vs CN¥0.20 profit in 1Q 2023)First quarter 2024 results: CN¥0.01 loss per share (down from CN¥0.20 profit in 1Q 2023). Revenue: CN¥246.4m (down 26% from 1Q 2023). Net loss: CN¥1.72m (down 106% from profit in 1Q 2023). Revenue is forecast to grow 44% p.a. on average during the next 2 years, compared to a 23% growth forecast for the Semiconductor industry in China.공시 • Apr 27Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 24, 2024Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 24, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Changzhou, Jiangsu China분석 기사 • Apr 21Macmic Science&Technology Co.,Ltd. (SHSE:688711) Stocks Pounded By 25% But Not Lagging Market On Growth Or PricingTo the annoyance of some shareholders, Macmic Science&Technology Co.,Ltd. ( SHSE:688711 ) shares are down a...Valuation Update With 7 Day Price Move • Apr 16Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥24.25, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 31x in the Semiconductor industry in China. Total loss to shareholders of 69% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥31.47 per share.Buy Or Sell Opportunity • Apr 16Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 34% to CN¥24.25. The fair value is estimated to be CN¥31.47, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 50% over the last 3 years. Earnings per share has grown by 27%. Revenue is forecast to grow by 115% in 2 years. Earnings are forecast to grow by 204% in the next 2 years.분석 기사 • Apr 12At CN¥26.69, Is Macmic Science&Technology Co.,Ltd. (SHSE:688711) Worth Looking At Closely?Macmic Science&Technology Co.,Ltd. ( SHSE:688711 ), might not be a large cap stock, but it saw a double-digit share...공시 • Mar 30Macmic Science&Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024Macmic Science&Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥28.11, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 32x in the Semiconductor industry in China. Total loss to shareholders of 62% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥32.05 per share.분석 기사 • Mar 04Macmic Science&Technology Co.,Ltd.'s (SHSE:688711) 25% Jump Shows Its Popularity With InvestorsMacmic Science&Technology Co.,Ltd. ( SHSE:688711 ) shareholders are no doubt pleased to see that the share price has...공시 • Mar 01Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces an Equity Buyback for CNY 50 million worth of its shares.Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at no more than CNY 46.99 per share. The purpose of the program is to use the repurchased shares for equity incentives or employee stock ownership plans or for converting corporate bonds issued by listed companies that can be converted into . If the company fails to use the shares for said purposes within 3 years of completion of the program, the unused or not transferred shares will be cancelled. The program will be funded from company's own funds. The plan will be valid for 6 months.Reported Earnings • Feb 24Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: CN¥0.76 (up from CN¥0.52 in FY 2022). Revenue: CN¥1.51b (up 63% from FY 2022). Net income: CN¥114.8m (up 46% from FY 2022). Profit margin: 7.6% (down from 8.5% in FY 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 8.4%. Earnings per share (EPS) also missed analyst estimates by 28%. Revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 24% growth forecast for the Semiconductor industry in China.Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥28.73, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 25x in the Semiconductor industry in China. Total loss to shareholders of 66% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥50.10 per share.Valuation Update With 7 Day Price Move • Dec 06Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥40.84, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 34x in the Semiconductor industry in China. Total loss to shareholders of 53% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥53.20 per share.Buying Opportunity • Dec 01Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 19%. The fair value is estimated to be CN¥54.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 52% over the last 3 years. Earnings per share has grown by 29%. Revenue is forecast to grow by 107% in 2 years. Earnings is forecast to grow by 202% in the next 2 years.New Risk • Nov 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (36% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (6.7% average weekly change). Profit margins are more than 30% lower than last year (7.1% net profit margin).New Risk • Oct 27New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 7.1% Last year net profit margin: 10% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (35% accrual ratio). Minor Risk Profit margins are more than 30% lower than last year (7.1% net profit margin).Reported Earnings • Oct 27Third quarter 2023 earnings: EPS and revenues miss analyst expectationsThird quarter 2023 results: EPS: CN¥0.15 (down from CN¥0.19 in 3Q 2022). Revenue: CN¥371.0m (up 32% from 3Q 2022). Net income: CN¥23.0m (down 21% from 3Q 2022). Profit margin: 6.2% (down from 10% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 18%. Earnings per share (EPS) also missed analyst estimates by 55%. Revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 25% growth forecast for the Semiconductor industry in China.Price Target Changed • Sep 19Price target decreased by 10% to CN¥76.50Down from CN¥85.46, the current price target is an average from 2 analysts. New target price is 47% above last closing price of CN¥52.08. Stock is down 4.4% over the past year. The company is forecast to post earnings per share of CN¥1.04 for next year compared to CN¥0.52 last year.Major Estimate Revision • Aug 24Consensus EPS estimates increase by 22%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has improved. 2023 revenue forecast increased from CN¥1.58b to CN¥1.62b. EPS estimate increased from CN¥0.957 to CN¥1.16 per share. Net income forecast to grow 91% next year vs 68% growth forecast for Semiconductor industry in China. Consensus price target broadly unchanged at CN¥85.85. Share price was steady at CN¥52.06 over the past week.Reported Earnings • Aug 18Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2023 results: EPS: CN¥0.21 (up from CN¥0.13 in 2Q 2022). Revenue: CN¥433.3m (up 125% from 2Q 2022). Net income: CN¥31.6m (up 59% from 2Q 2022). Profit margin: 7.3% (down from 10% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 19%. Earnings per share (EPS) missed analyst estimates by 20%. Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 24% growth forecast for the Semiconductor industry in China.공시 • Jun 28Macmic Science&Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 18, 2023Macmic Science&Technology Co.,Ltd. announced that they will report first half, 2023 results on Aug 18, 2023Major Estimate Revision • May 02Consensus revenue estimates fall by 13%The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥1.76b to CN¥1.53b. EPS estimate fell from CN¥1.18 to CN¥1.10 per share. Net income forecast to grow 76% next year vs 61% growth forecast for Semiconductor industry in China. Consensus price target down from CN¥96.50 to CN¥92.50. Share price was steady at CN¥75.08 over the past week.Reported Earnings • Apr 26First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2023 results: EPS: CN¥0.22 (up from CN¥0.086 in 1Q 2022). Revenue: CN¥331.2m (up 137% from 1Q 2022). Net income: CN¥30.9m (up 152% from 1Q 2022). Profit margin: 9.3% (up from 8.8% in 1Q 2022). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 10%. Earnings per share (EPS) missed analyst estimates by 8.3%. Revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 24% growth forecast for the Semiconductor industry in China.Major Estimate Revision • Feb 23Consensus revenue estimates increase by 28%The consensus outlook for revenues in fiscal year 2023 has improved. 2023 revenue forecast increased from CN¥1.37b to CN¥1.76b. EPS estimate increased from CN¥1.08 to CN¥1.18 per share. Net income forecast to grow 110% next year vs 45% growth forecast for Semiconductor industry in China. Consensus price target broadly unchanged at CN¥97.23. Share price fell 5.8% to CN¥80.90 over the past week.Reported Earnings • Feb 18Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2022 results: EPS: CN¥0.56. Revenue: CN¥929.2m (up 69% from FY 2021). Net income: CN¥77.2m (up 12% from FY 2021). Profit margin: 8.3% (down from 13% in FY 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.2%. Earnings per share (EPS) missed analyst estimates by 19%. Revenue is forecast to grow 35% p.a. on average during the next 2 years, compared to a 25% growth forecast for the Semiconductor industry in China.Price Target Changed • Jan 11Price target increased to CN¥97.57Up from CN¥78.35, the current price target is an average from 2 analysts. New target price is 7.5% above last closing price of CN¥90.76. Stock is up 12% over the past year. The company is forecast to post earnings per share of CN¥0.70 for next year compared to CN¥0.60 last year.Reported Earnings • Oct 18Third quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.072 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.21 (up from CN¥0.072 in 3Q 2021). Revenue: CN¥282.0m (up 108% from 3Q 2021). Net income: CN¥29.0m (up 96% from 3Q 2021). Profit margin: 10% (in line with 3Q 2021). Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 26% growth forecast for the Semiconductor industry in China.Price Target Changed • Oct 11Price target decreased to CN¥78.35Down from CN¥104, the current price target is an average from 2 analysts. New target price is 51% above last closing price of CN¥51.72. Stock is down 34% over the past year. The company is forecast to post earnings per share of CN¥0.67 for next year compared to CN¥0.60 last year.Buying Opportunity • Oct 11Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 34%. The fair value is estimated to be CN¥66.47, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 30% over the last 3 years. Earnings per share has grown by 38%. Revenue is forecast to grow by 124% in 2 years. Earnings is forecast to grow by 158% in the next 2 years.Buying Opportunity • Sep 19Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be CN¥74.50, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 30% over the last 3 years. Earnings per share has grown by 38%. Revenue is forecast to grow by 124% in 2 years. Earnings is forecast to grow by 171% in the next 2 years.Reported Earnings • Aug 18Second quarter 2022 earnings releasedSecond quarter 2022 results: EPS: CN¥0.15. Net income: CN¥20.0m (up CN¥20.0m from 2Q 2021). Over the next year, revenue is forecast to grow 55%, compared to a 48% growth forecast for the Semiconductor industry in China.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 688711 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: 688711 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Macmic Science&TechnologyLtd 배당 수익률 vs 시장688711의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (688711)0%시장 하위 25% (CN)0.4%시장 상위 25% (CN)1.9%업계 평균 (Semiconductor)0.2%분석가 예측 (688711) (최대 3년)0%주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 688711 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 688711 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 688711 CN 시장에서 주목할만한 배당금을 지급하지 않습니다.주주 현금 배당현금 흐름 범위: 688711 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YCN 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 06:58종가2026/05/22 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Macmic Science&Technology Co.,Ltd.는 3명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Min ZouJefferies LLCJian PanTianfeng Securities Brokerage Co., LtdFang WangZhongtai Securities Co. Ltd.
공시 • Dec 06Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces an Equity Buyback for CNY 50 million worth of its shares.Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at no more than CNY 30.12 per share. The purpose of the program is to use the repurchased shares for equity incentives or employee stock ownership plans or for converting corporate bonds issued by listed companies that can be converted into shares. If the company fails to use the shares for said purposes within 3 years of completion of the program, the unused or not transferred shares will be cancelled. The program will be funded from company's own funds. The plan will be valid for 12 months.
공시 • Mar 01Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces an Equity Buyback for CNY 50 million worth of its shares.Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at no more than CNY 46.99 per share. The purpose of the program is to use the repurchased shares for equity incentives or employee stock ownership plans or for converting corporate bonds issued by listed companies that can be converted into . If the company fails to use the shares for said purposes within 3 years of completion of the program, the unused or not transferred shares will be cancelled. The program will be funded from company's own funds. The plan will be valid for 6 months.
Buy Or Sell Opportunity • May 21Now 27% undervaluedThe stock has been flat over the last 90 days, currently trading at CN¥32.57. The fair value is estimated to be CN¥44.50, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable.
New Risk • May 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 36% per year over the past 5 years. Minor Risks High level of debt (55% net debt to equity). Share price has been volatile over the past 3 months (8.3% average weekly change). Large one-off items impacting financial results.
Reported Earnings • May 01Full year 2025 earnings released: EPS: CN¥0.08 (vs CN¥0.068 loss in FY 2024)Full year 2025 results: EPS: CN¥0.08 (up from CN¥0.068 loss in FY 2024). Revenue: CN¥1.35b (up 1.2% from FY 2024). Net income: CN¥17.1m (up CN¥31.6m from FY 2024). Profit margin: 1.3% (up from net loss in FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.
공시 • Apr 30Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 20, 2026Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 20, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Changzhou, Jiangsu China
공시 • Mar 30Macmic Science&Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 30, 2026Macmic Science&Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026
Reported Earnings • Mar 05Full year 2025 earnings released: EPS: CN¥0.082 (vs CN¥0.068 loss in FY 2024)Full year 2025 results: EPS: CN¥0.082 (up from CN¥0.068 loss in FY 2024). Revenue: CN¥1.35b (up 1.1% from FY 2024). Net income: CN¥17.4m (up CN¥31.9m from FY 2024). Profit margin: 1.3% (up from net loss in FY 2024). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance.
공시 • Dec 26Macmic Science&Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 30, 2026Macmic Science&Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 30, 2026
Reported Earnings • Oct 31Third quarter 2025 earnings released: EPS: CN¥0.011 (vs CN¥0.007 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.011 (up from CN¥0.007 in 3Q 2024). Revenue: CN¥302.9m (down 12% from 3Q 2024). Net income: CN¥2.39m (up 56% from 3Q 2024). Profit margin: 0.8% (up from 0.4% in 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.
공시 • Sep 30Macmic Science&Technology Co.,Ltd. to Report Q3, 2025 Results on Oct 31, 2025Macmic Science&Technology Co.,Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025
New Risk • Aug 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (13% operating cash flow to total debt). Earnings have declined by 11% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.0% average weekly change).
공시 • Jun 30Macmic Science&Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 29, 2025Macmic Science&Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 29, 2025
New Risk • Jun 05New major risk - Revenue and earnings growthEarnings have declined by 11% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (13% operating cash flow to total debt). Earnings have declined by 11% per year over the past 5 years.
Reported Earnings • Apr 20Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: CN¥0.068 loss per share (down from CN¥0.55 profit in FY 2023). Revenue: CN¥1.33b (down 12% from FY 2023). Net loss: CN¥14.5m (down 113% from profit in FY 2023). Revenue missed analyst estimates by 4.0%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 21% p.a. on average during the next 2 years, compared to a 23% growth forecast for the Semiconductor industry in China. Over the last 3 years on average, earnings per share has fallen by 24% per year whereas the company’s share price has fallen by 21% per year.
공시 • Apr 15Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 09, 2025Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 09, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Changzhou, Jiangsu China
New Risk • Apr 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (7.3% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (7.7% average weekly change).
공시 • Mar 28Macmic Science&Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 29, 2025Macmic Science&Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025
Reported Earnings • Mar 02Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: CN¥0.066 loss per share (down from CN¥0.55 profit in FY 2023). Revenue: CN¥1.33b (down 12% from FY 2023). Net loss: CN¥14.1m (down 112% from profit in FY 2023). Revenue missed analyst estimates by 4.0%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 21% p.a. on average during the next 2 years, compared to a 24% growth forecast for the Semiconductor industry in China. Over the last 3 years on average, earnings per share has fallen by 24% per year whereas the company’s share price has fallen by 27% per year.
공시 • Dec 27Macmic Science&Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025Macmic Science&Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025
공시 • Dec 06Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces an Equity Buyback for CNY 50 million worth of its shares.Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at no more than CNY 30.12 per share. The purpose of the program is to use the repurchased shares for equity incentives or employee stock ownership plans or for converting corporate bonds issued by listed companies that can be converted into shares. If the company fails to use the shares for said purposes within 3 years of completion of the program, the unused or not transferred shares will be cancelled. The program will be funded from company's own funds. The plan will be valid for 12 months.
분석 기사 • Nov 11Macmic Science&Technology Co.,Ltd.'s (SHSE:688711) Shares Leap 28% Yet They're Still Not Telling The Full StoryDespite an already strong run, Macmic Science&Technology Co.,Ltd. ( SHSE:688711 ) shares have been powering on, with a...
Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.007 (vs CN¥0.11 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.007 (down from CN¥0.11 in 3Q 2023). Revenue: CN¥343.1m (down 7.5% from 3Q 2023). Net income: CN¥1.53m (down 93% from 3Q 2023). Profit margin: 0.4% (down from 6.2% in 3Q 2023). Revenue is forecast to grow 29% p.a. on average during the next 3 years, compared to a 23% growth forecast for the Semiconductor industry in China. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 36% per year, which means it is performing significantly worse than earnings.
분석 기사 • Oct 16Macmic Science&TechnologyLtd (SHSE:688711) Will Want To Turn Around Its Return TrendsIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...
Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥17.40, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 32x in the Semiconductor industry in China. Total loss to shareholders of 73% over the past three years.
공시 • Sep 30Macmic Science&Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 31, 2024Macmic Science&Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 24%After last week's 24% share price gain to CN¥14.80, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 27x in the Semiconductor industry in China. Total loss to shareholders of 70% over the past three years.
분석 기사 • Sep 26Why We're Not Concerned About Macmic Science&Technology Co.,Ltd.'s (SHSE:688711) Share PriceWhen close to half the companies in China have price-to-earnings ratios (or "P/E's") below 27x, you may consider Macmic...
New Risk • Sep 14New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.5x net interest cover). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.1% net profit margin).
분석 기사 • Aug 29We Think That There Are More Issues For Macmic Science&TechnologyLtd (SHSE:688711) Than Just Sluggish EarningsA lackluster earnings announcement from Macmic Science&Technology Co.,Ltd. ( SHSE:688711 ) last week didn't sink the...
Reported Earnings • Aug 23Second quarter 2024 earnings released: EPS: CN¥0.023 (vs CN¥0.15 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.023 (down from CN¥0.15 in 2Q 2023). Revenue: CN¥390.2m (down 9.9% from 2Q 2023). Net income: CN¥4.23m (down 87% from 2Q 2023). Profit margin: 1.1% (down from 7.3% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Semiconductor industry in China.
New Risk • Jul 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (25% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Profit margins are more than 30% lower than last year (5.9% net profit margin).
분석 기사 • Jul 22Is It Too Late To Consider Buying Macmic Science&Technology Co.,Ltd. (SHSE:688711)?Macmic Science&Technology Co.,Ltd. ( SHSE:688711 ), might not be a large cap stock, but it saw a double-digit share...
공시 • Jun 28Macmic Science&Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 23, 2024Macmic Science&Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 23, 2024
분석 기사 • Jun 13Is Macmic Science&TechnologyLtd (SHSE:688711) A Risky Investment?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Valuation Update With 7 Day Price Move • Jun 13Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥24.77, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 31x in the Semiconductor industry in China. Total loss to shareholders of 60% over the past year.
Reported Earnings • Apr 27First quarter 2024 earnings released: CN¥0.01 loss per share (vs CN¥0.20 profit in 1Q 2023)First quarter 2024 results: CN¥0.01 loss per share (down from CN¥0.20 profit in 1Q 2023). Revenue: CN¥246.4m (down 26% from 1Q 2023). Net loss: CN¥1.72m (down 106% from profit in 1Q 2023). Revenue is forecast to grow 44% p.a. on average during the next 2 years, compared to a 23% growth forecast for the Semiconductor industry in China.
공시 • Apr 27Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 24, 2024Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 24, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Changzhou, Jiangsu China
분석 기사 • Apr 21Macmic Science&Technology Co.,Ltd. (SHSE:688711) Stocks Pounded By 25% But Not Lagging Market On Growth Or PricingTo the annoyance of some shareholders, Macmic Science&Technology Co.,Ltd. ( SHSE:688711 ) shares are down a...
Valuation Update With 7 Day Price Move • Apr 16Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥24.25, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 31x in the Semiconductor industry in China. Total loss to shareholders of 69% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥31.47 per share.
Buy Or Sell Opportunity • Apr 16Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 34% to CN¥24.25. The fair value is estimated to be CN¥31.47, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 50% over the last 3 years. Earnings per share has grown by 27%. Revenue is forecast to grow by 115% in 2 years. Earnings are forecast to grow by 204% in the next 2 years.
분석 기사 • Apr 12At CN¥26.69, Is Macmic Science&Technology Co.,Ltd. (SHSE:688711) Worth Looking At Closely?Macmic Science&Technology Co.,Ltd. ( SHSE:688711 ), might not be a large cap stock, but it saw a double-digit share...
공시 • Mar 30Macmic Science&Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024Macmic Science&Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024
Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥28.11, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 32x in the Semiconductor industry in China. Total loss to shareholders of 62% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥32.05 per share.
분석 기사 • Mar 04Macmic Science&Technology Co.,Ltd.'s (SHSE:688711) 25% Jump Shows Its Popularity With InvestorsMacmic Science&Technology Co.,Ltd. ( SHSE:688711 ) shareholders are no doubt pleased to see that the share price has...
공시 • Mar 01Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces an Equity Buyback for CNY 50 million worth of its shares.Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at no more than CNY 46.99 per share. The purpose of the program is to use the repurchased shares for equity incentives or employee stock ownership plans or for converting corporate bonds issued by listed companies that can be converted into . If the company fails to use the shares for said purposes within 3 years of completion of the program, the unused or not transferred shares will be cancelled. The program will be funded from company's own funds. The plan will be valid for 6 months.
Reported Earnings • Feb 24Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: CN¥0.76 (up from CN¥0.52 in FY 2022). Revenue: CN¥1.51b (up 63% from FY 2022). Net income: CN¥114.8m (up 46% from FY 2022). Profit margin: 7.6% (down from 8.5% in FY 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 8.4%. Earnings per share (EPS) also missed analyst estimates by 28%. Revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 24% growth forecast for the Semiconductor industry in China.
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥28.73, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 25x in the Semiconductor industry in China. Total loss to shareholders of 66% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥50.10 per share.
Valuation Update With 7 Day Price Move • Dec 06Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥40.84, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 34x in the Semiconductor industry in China. Total loss to shareholders of 53% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥53.20 per share.
Buying Opportunity • Dec 01Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 19%. The fair value is estimated to be CN¥54.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 52% over the last 3 years. Earnings per share has grown by 29%. Revenue is forecast to grow by 107% in 2 years. Earnings is forecast to grow by 202% in the next 2 years.
New Risk • Nov 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (36% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (6.7% average weekly change). Profit margins are more than 30% lower than last year (7.1% net profit margin).
New Risk • Oct 27New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 7.1% Last year net profit margin: 10% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (35% accrual ratio). Minor Risk Profit margins are more than 30% lower than last year (7.1% net profit margin).
Reported Earnings • Oct 27Third quarter 2023 earnings: EPS and revenues miss analyst expectationsThird quarter 2023 results: EPS: CN¥0.15 (down from CN¥0.19 in 3Q 2022). Revenue: CN¥371.0m (up 32% from 3Q 2022). Net income: CN¥23.0m (down 21% from 3Q 2022). Profit margin: 6.2% (down from 10% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 18%. Earnings per share (EPS) also missed analyst estimates by 55%. Revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 25% growth forecast for the Semiconductor industry in China.
Price Target Changed • Sep 19Price target decreased by 10% to CN¥76.50Down from CN¥85.46, the current price target is an average from 2 analysts. New target price is 47% above last closing price of CN¥52.08. Stock is down 4.4% over the past year. The company is forecast to post earnings per share of CN¥1.04 for next year compared to CN¥0.52 last year.
Major Estimate Revision • Aug 24Consensus EPS estimates increase by 22%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has improved. 2023 revenue forecast increased from CN¥1.58b to CN¥1.62b. EPS estimate increased from CN¥0.957 to CN¥1.16 per share. Net income forecast to grow 91% next year vs 68% growth forecast for Semiconductor industry in China. Consensus price target broadly unchanged at CN¥85.85. Share price was steady at CN¥52.06 over the past week.
Reported Earnings • Aug 18Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2023 results: EPS: CN¥0.21 (up from CN¥0.13 in 2Q 2022). Revenue: CN¥433.3m (up 125% from 2Q 2022). Net income: CN¥31.6m (up 59% from 2Q 2022). Profit margin: 7.3% (down from 10% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 19%. Earnings per share (EPS) missed analyst estimates by 20%. Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 24% growth forecast for the Semiconductor industry in China.
공시 • Jun 28Macmic Science&Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 18, 2023Macmic Science&Technology Co.,Ltd. announced that they will report first half, 2023 results on Aug 18, 2023
Major Estimate Revision • May 02Consensus revenue estimates fall by 13%The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥1.76b to CN¥1.53b. EPS estimate fell from CN¥1.18 to CN¥1.10 per share. Net income forecast to grow 76% next year vs 61% growth forecast for Semiconductor industry in China. Consensus price target down from CN¥96.50 to CN¥92.50. Share price was steady at CN¥75.08 over the past week.
Reported Earnings • Apr 26First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2023 results: EPS: CN¥0.22 (up from CN¥0.086 in 1Q 2022). Revenue: CN¥331.2m (up 137% from 1Q 2022). Net income: CN¥30.9m (up 152% from 1Q 2022). Profit margin: 9.3% (up from 8.8% in 1Q 2022). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 10%. Earnings per share (EPS) missed analyst estimates by 8.3%. Revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 24% growth forecast for the Semiconductor industry in China.
Major Estimate Revision • Feb 23Consensus revenue estimates increase by 28%The consensus outlook for revenues in fiscal year 2023 has improved. 2023 revenue forecast increased from CN¥1.37b to CN¥1.76b. EPS estimate increased from CN¥1.08 to CN¥1.18 per share. Net income forecast to grow 110% next year vs 45% growth forecast for Semiconductor industry in China. Consensus price target broadly unchanged at CN¥97.23. Share price fell 5.8% to CN¥80.90 over the past week.
Reported Earnings • Feb 18Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2022 results: EPS: CN¥0.56. Revenue: CN¥929.2m (up 69% from FY 2021). Net income: CN¥77.2m (up 12% from FY 2021). Profit margin: 8.3% (down from 13% in FY 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.2%. Earnings per share (EPS) missed analyst estimates by 19%. Revenue is forecast to grow 35% p.a. on average during the next 2 years, compared to a 25% growth forecast for the Semiconductor industry in China.
Price Target Changed • Jan 11Price target increased to CN¥97.57Up from CN¥78.35, the current price target is an average from 2 analysts. New target price is 7.5% above last closing price of CN¥90.76. Stock is up 12% over the past year. The company is forecast to post earnings per share of CN¥0.70 for next year compared to CN¥0.60 last year.
Reported Earnings • Oct 18Third quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.072 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.21 (up from CN¥0.072 in 3Q 2021). Revenue: CN¥282.0m (up 108% from 3Q 2021). Net income: CN¥29.0m (up 96% from 3Q 2021). Profit margin: 10% (in line with 3Q 2021). Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 26% growth forecast for the Semiconductor industry in China.
Price Target Changed • Oct 11Price target decreased to CN¥78.35Down from CN¥104, the current price target is an average from 2 analysts. New target price is 51% above last closing price of CN¥51.72. Stock is down 34% over the past year. The company is forecast to post earnings per share of CN¥0.67 for next year compared to CN¥0.60 last year.
Buying Opportunity • Oct 11Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 34%. The fair value is estimated to be CN¥66.47, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 30% over the last 3 years. Earnings per share has grown by 38%. Revenue is forecast to grow by 124% in 2 years. Earnings is forecast to grow by 158% in the next 2 years.
Buying Opportunity • Sep 19Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be CN¥74.50, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 30% over the last 3 years. Earnings per share has grown by 38%. Revenue is forecast to grow by 124% in 2 years. Earnings is forecast to grow by 171% in the next 2 years.
Reported Earnings • Aug 18Second quarter 2022 earnings releasedSecond quarter 2022 results: EPS: CN¥0.15. Net income: CN¥20.0m (up CN¥20.0m from 2Q 2021). Over the next year, revenue is forecast to grow 55%, compared to a 48% growth forecast for the Semiconductor industry in China.